Torinat 10mg Tablet

Torinat 10mg tablet is an antineoplastic drug belonging to the class of mTOR kinase inhibitors, containing the active ingredient everolimus. It is indicated for advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and subependymal giant cell astrocytoma (tumours located in the brain ventricles). Maintenance of good oral hygiene and regular dental check-ups are important during treatment, as this medicine can cause oral sores or ulcers. For subependymal giant cell astrocytoma, it is often used in combination with cyclophosphamide, an alkylating agent.

Treatment with this medicine increases the risk of bacterial and viral infections. If you have a history of Hepatitis B infection, Torinat 10mg tablet may increase the risk of reactivation. Inform your healthcare provider if you develop fever, chills, cough, yellowing of skin, joint pain, or swelling during treatment. Sun and UV light exposure should be minimised by wearing protective clothing and applying sunscreen regularly, as this medicine may increase the risk of skin cancers. Grapefruit juice and grapefruit should be avoided during treatment.

This tablet is not recommended for adolescents and children under 18 years of age. Seek immediate medical attention if you experience shortness of breath, chest pain, or worsening cough. During treatment, your doctor may perform periodic monitoring of white blood cell counts, platelets, blood glucose, electrolytes, and renal function to prevent serious adverse effects. This medicine has the potential to cause kidney dysfunction. Inform your doctor if you have pre-existing liver disease, heart failure, elevated blood cholesterol, or hypertension before starting treatment. Live vaccines should be avoided, and close contact with individuals who have recently received live vaccines should be minimised.

Advanced breast cancer Advanced renal cell carcinoma Advanced pancreatic neuroendocrine tumours Treatment of subependymal giant cell astrocytoma

Torinat 10mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumours and improve outcomes in patients.

Take the Torinat 10mg tablet as advised by your physician. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Difficulty breathing, or swallowing Swelling of face, lips, tongue, throat Severe itching, red rash, raised bumps Common Infection (chills, increased temperature) Coughing Wheezing Excessive thirst High urine output or severely decreased urine output Tiredness Bleeding Increased appetite with weight loss

Torinat 10mg tablet has the tendency to cause harm to the unborn foetus. Inform your healthcare provider before starting this treatment if you are pregnant, or planning for pregnancy. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug. Discuss effective birth control methods with your healthcare provider and use them during the treatment for 8 weeks after your last dose. This medicine passes into breast milk. Hence, it is not recommended to breastfeed during this treatment. The occurrence of mouth ulcers or sores is pretty common during this treatment, so your healthcare provider will prescribe a mouthwash. Use the mouthwash as recommended which helps prevent and manage the symptoms.